News & Articles

Company’s latest test enables differential diagnosis between COVID-19, flu and RSV infection

New sample collection kit enables convenient and safe collection, transportation and handling of pathogenic samples including COVID-19 and influenza

Study by University of Manchester reassures patients that it is safe to take blood pressure medication during the pandemic

Which new products made the most difference to your lab work this year?

New kit aims to provide highly sensitive and efficient approach for studying mitophagy impairment in conditions such as Parkinson’s and Alzheimer’s

The study leverages the Tapestri Platform to illustrate the single-cell atlas of acute myeloid leukemia (AML) with multi-omics, describing the clonality underlying therapeutic resistance

Proven, scalable platform aims to increase dose yields and reduces process development time for cell and gene therapies

The collaboration will focus on the investigation of clinically relevant molecular targets for use in the development of advanced diagnostic testing for epilepsy

Veklury is first FDA-approved treatment for COVID-19 in the US, and aims to shorten time to recovery by five days

Roche and Atea partner to jointly develop AT-527, an orally administered direct-acting antiviral (DAA) currently in Phase 2 clinical trials

Watch world-renowned experts and connect with leading innovators on the hottest topics, new developments and latest technologies in neuroscience

The hypercube algorithm aims to enable regular, cost-effective screening in multiple contexts

The company aims to meet the increased demand for approved media to maintain virus viability from sample collection to the lab

Join us Thursday, November 5, to learn how to introduce base editing technology into your cell therapy pipeline

The TaqPath test is authorized for use with the Everlywell COVID-19 Test Home Collection Kit, which enables individuals to self-collect nasal swab specimens

Learn the importance of low LoD tests and discover the most sensitive kits available, as determined by the FDA’s SARS-CoV-2 Reference Panel

Find out how Zymo Research’s state-of-the-art tools are helping laboratories and government agencies facilitate large-scale COVID-19 testing in the United States

Experts share novel techniques for accelerating monoclonal antibody discovery and development to bring hope to COVID-19 patients

Watch this webinar on demand to learn about the host immune response to COVID-19

Watch this on-demand webinar to learn how to perform untargeted/semi-targeted metabolomic studies to discover novel biomarkers by mass spectrometry